{
    "clinical_study": {
        "@rank": "121056", 
        "arm_group": [
            {
                "arm_group_label": "Control Group", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will receive conventional care and keep on their usual SMBG methods. Additionally, each patient will also wear a CGMS device for 72h in the first week and the last week, respectively."
            }, 
            {
                "arm_group_label": "SMBG-4 Group", 
                "arm_group_type": "Active Comparator", 
                "description": "Capillary glucose level is measured using finger stick method by 4 times (fasting plus post-meals) every other day. Additionally, each patient will also wear a CGMS device for 72h in the first week and the last week, respectively."
            }, 
            {
                "arm_group_label": "SMBG-7 Group", 
                "arm_group_type": "Active Comparator", 
                "description": "Capillary glucose level is measured using finger stick method by 7 times (fasting, pre-meals, post-meals and bedtime altogether) every other day. Additionally, each patient will also wear a CGMS device for 72h in the first week and the last week, respectively."
            }
        ], 
        "brief_summary": {
            "textblock": "Self-monitoring of blood glucose (SMBG) is a common way to assess glycemic control in\n      diabetes management. Multiple times of blood glucose measurements by fingerstick in the same\n      day are of tough challenge to it. The changes and variations of glucose excursion in senior\n      diabetics with Coronary Artery Disease (CAD)involve a safety issue besides glycated\n      hemoglobin (GHb) value. The goal of this study is to explore modified SMBG protocols for\n      precisely monitoring and predicting glycemic excursion, variability in senior type 2\n      diabetics with CAD."
        }, 
        "brief_title": "SMBG Protocols Predicting Glucose Levels in Senior Diabetics With CAD", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diabetes Mellitus, Type 2", 
            "Coronary Artery Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of type 2 diabetes\n\n          -  Clinical diagnosis of coronary artery disease\n\n          -  Age \u226565 years\n\n          -  The blood glucose is controlled by diets and (or) oral hypoglycemic drugs\n\n          -  BMI\u226428 kg/m\u00b2\n\n          -  Being able to monitor and record capillary glucose value by themselves at home\n\n        Exclusion Criteria:\n\n          -  Diabetic ketoacidosis (DKA)\n\n          -  Acute cardiovascular events\n\n          -  Anemia\n\n          -  Insulin treatment\n\n          -  Incapable to perform SMBG at home"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "65 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01954771", 
            "org_study_id": "Z131100004013044"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Control Group", 
                    "SMBG-4 Group", 
                    "SMBG-7 Group"
                ], 
                "intervention_name": "SMBG", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "Control Group", 
                    "SMBG-4 Group", 
                    "SMBG-7 Group"
                ], 
                "description": "In this study, according to the protocol, all the patients will follow their prespecified SMBG methods and periodically visit doctor, but therapies will not be adjusted unless they experience severe hypoglycemia or hyperglycemia episodes. The expected duration of the trial is 12 weeks.", 
                "intervention_name": "CGMS", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 29, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "state": "Beijing", 
                    "zip": "100029"
                }, 
                "name": "Capital Medical University Affiliated Beijing Anzhen Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Prospective, Randomized, Controlled Study on Self-monitoring of Blood Glucose (SMBG) Protocols in Predicting Glucose Levels in Senior Patients With Type 2 Diabetes Mellitus (T2DM) and Coronary Artery Disease (CAD)", 
        "overall_contact": {
            "email": "zhouys01@sina.cn", 
            "last_name": "Yingsheng Zhou, MD; PhD", 
            "phone": "0086-10-64456185"
        }, 
        "overall_official": {
            "affiliation": "Capital Medical University Affiliated Beijing Anzhen Hospital", 
            "last_name": "Yingsheng Zhou, MD; PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Beijing Municipal Science and Technology Commission", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Evaluation of peak and nadir glucose profiles from SMBG protocols and continuous glucose monitoring system (CGMS)", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01954771"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Beijing Anzhen Hospital", 
            "investigator_full_name": "Yingsheng Zhou, MD; PhD", 
            "investigator_title": "Director of Endocrinology and Metabolism Department of Capital Medical University Affiliated Beijing Anzhen Hospital", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "The correlation study between GHb and glycemic profiles of MBG (mean blood glucose) or AUC (area under the curve) from SMBG protocols and CGMS", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Events of hypoglycemia (\u226450mg/dL or 2.8mmol/L) captured by SMBG method and CGMS", 
                "safety_issue": "Yes", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "Beijing Anzhen Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Beijing Anzhen Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}